Heart biological age
Biomarker1 paper1 finding
- Human trial1
Interventions
1Semaglutide
downin humans1
1 study
Semaglutide
downin humans1
Semaglutide decreases heart biological age in humans (approximately 2 to 4 years versus placebo).
“Semaglutide reduced heart biological age by approximately 2 to 4 years versus placebo”
Human trialheartup to 156 weeksn = 10,052
Semaglutide reduces proteomic organ-specific biological age across randomized clinical trials · Research Square · 22 Sep 2026 · Preprint
Latest
1Research SquareHuman trialPreprint